Ratings, Reviews Summary for OVCON-35 (WARNER CHILCOTT)
April 2024 Overall Patient opinion of OVCON-35: 2.8 (somewhat satisfied)
(based on 480 reviews )Ratings by Age Group for OVCON-35
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Age Group | Number of Reviews | Average Rating |
|---|---|---|
| Pediatric (Under 18) | 15 | 3.2 |
| Age 18 to 24 | 190 | 3.0 |
| Age 25 to 34 | 193 | 3.0 |
| Age 35 to 44 | 62 | 2.5 |
| Age 45 to 54 | 11 | 3.2 |
| Age 55 to 64 | ||
| Age 65 to 74 | ||
| Age 75 and up |
Ratings by Sex for OVCON-35
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Sex | Number of Reviews | Average Rating |
|---|---|---|
| Male | 6 | 2.5 |
| Female | 466 | 2.88 |
| Not Specified | 8 | 1.75 |
Why OVCON-35* (Ethinyl estradiol; norethindrone ) is Prescribed for Patients*
Patient opinion of OVCON-35: somewhat satisfied (average rating score: 2.89)
(based on 907 reviews - combined drugs with same active ingredient - see footnote for timeframe )Top 10 Reasons for taking** OVCON-35
(reported on Ask a Patient)
| Reason | # of Ask a Patient Reviews | |
|---|---|---|
| 1 | Contraception* | 234 |
| 2 | Endometriosis* | 14 |
| 3 | Ovarian cyst* | 4 |
| 4 | Menstruation irregular* | 4 |
| 5 | Menorrhagia* | 2 |
| 6 | Dysmenorrhoea* | 2 |
| 7 | Muscle spasms | 2 |
| 8 | Acne | 2 |
| 9 | Ovulation pain | 1 |
| 10 | Post coital contraception | 1 |
*Also included as reason for taking drug in FDA Adverse Events summary.
Top 20 Side Effects of OVCON-35 **
(reported on Ask a Patient)
| Side Effect | # of Ask a Patient Reviews | |
|---|---|---|
| 1 | Weight increased | 221 |
| 2 | Nausea* | 182 |
| 3 | Muscle spasms | 147 |
| 4 | Headache* | 145 |
| 5 | Depression | 144 |
| 6 | Mood swings | 141 |
| 7 | Haemorrhage | 128 |
| 8 | Mood altered | 127 |
| 9 | Abdominal distension | 115 |
| 10 | Breast tenderness | 107 |
| 11 | Somnolence | 80 |
| 12 | Fatigue | 66 |
| 13 | Crying | 63 |
| 14 | Menstruation irregular | 62 |
| 15 | Acne | 57 |
| 16 | Anxiety* | 57 |
| 17 | Loss of libido | 56 |
| 18 | Pain* | 45 |
| 19 | Libido decreased | 45 |
| 20 | Irritability | 41 |
*Important! This side effect is also associated with Adverse Event Reports (serious reaction); Also see charts in FDA Adverse Events summary.
Please click here for Safety Information and FDA Adverse Events summary for OVCON-35
* Reviews for drugs with the same active ingredients have been aggregated in this analysis: Ethinyl estradiol; norethindrone (Nortrel 0.5/35-28, Ortho-novum 7/14-21, N.e.e. 1/35 28, Norcept-e 1/35 21, Ortho-novum 7/14-28, Ortho-novum 10/11-28, Norethin 1/35e-28, Modicon 21, Gencept 10/11-28, Gencept 10/11-21, Norinyl 1+35 21-day, Brevicon 28-day, Balziva-28, Ortho-novum 1/35-21, Norcept-e 1/35 28, Brevicon 21-day, N.e.e. 1/35 21, Tri-norinyl 28-day, Norethin 1/35e-21, Ortho-novum 10/11-21, Tri-norinyl 21-day, Ovcon-50, Cyclafem 1/35, Wera, Alyacen 7/7/7, Dasetta 7/7/7, Pirmella 7/7/7, Philith, Ortho-novum 7/7/7-28, Ortho-novum 1/35-28, Femcon fe, Vyfemla, Balziva-21, Nortrel 1/35-28, Cyclafem 7/7/7, Nortrel, Pirmella 1/35, Nortrel 7/7/7, Modicon 28, Gildagia, Nortrel 1/35-21, Norinyl 1+35 28-day, Alyacen 1/35, Dasetta 1/35, Ortho-novum 7/7/7-21, Nortrel 0.5/35-21, Briellyn, Aranelle, Ovcon-35)
**Historical Analytics (through 2015) of AskaPatient Reviews Provided by Druginformer.com